Skip to main content
Equibles
NRC logo

NRC · Nrc Health · Earnings Call Transcripts & Audio

Track NRC — free

Use NRC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NRC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.00 +0.07 (+0.33%)
Russell 2000 member Rebalance outlook locked
Market Cap
$462.96M
Shares
22.12M

Nrc Health Earnings Call Transcripts

Quarterly earnings calls for Nrc Health (NRC), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲10.1% $38.30M $9.63M '21 Q4 22-02-10 ▲8.4% $38.44M $8.54M '22 Q1 22-05-05 ▲2.4% $37.29M $8.32M '22 Q2 22-08-04 ▼0.2% $37.69M $8.30M '22 Q3 22-11-03 ▼0.4% $38.14M $6.64M '22 Q4 23-02-16 ▼5.1% $36.47M $6.96M '23 Q1 23-05-04 ▼3% $36.16M $7.27M '23 Q2 23-08-03 ▲0.7% $37.95M $7.88M '23 Q3 23-11-08 ▼0.4% $38.00M $8.86M '23 Q4 24-02-13 ▼3.2% $35.31M $6.36M '24 Q1 24-05-07 ▼3.2% $35.02M $6.17M '24 Q2 24-08-06 ▼2.8% $34.04M −$106,000 '25 Q2 25-07-28 ▼3.4% $34.61M $4.12M '25 Q3 25-10-27 ▼4.6% $35.19M $1.80M '25 Q4 26-02-03 ▲3.7% $34.80M $3.22M '26 Q1 26-04-28 LATEST ▲4% $35.39M −$3.28M '26 Q2 26-07-28
Conference
Investor event
2027-01-13
Nrc Health (NRC) January 2027 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-23
Nrc Health (NRC) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-28
Nrc Health (NRC) Q2 2026 Earnings Call
Revenue
$35.39M
▲ 4% YoY
Diluted EPS
$-0.15
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-28
Nrc Health (NRC) Q1 2026 Earnings Call
Revenue
$34.80M
▲ 3.7% YoY
Diluted EPS
$0.14
▼ 44% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-03
Nrc Health (NRC) Q4 2025 Earnings Call Transcript
Confident tone TRCV growth and recurring revenue Capital allocation and profitability Customer retention and success
Revenue
$35.19M*
▼ 4.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-27
Nrc Health (NRC) Q3 2025 Earnings Call
Revenue
$34.61M
▼ 3.4% YoY
Diluted EPS
$0.18
▼ 25% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-28
Nrc Health (NRC) Q2 2025 Earnings Call
Revenue
$34.04M
▼ 2.8% YoY
Diluted EPS
$-0.01
▼ 103.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Nrc Health (NRC) Q2 2024 Earnings Call
Revenue
$35.02M
▼ 3.2% YoY
Diluted EPS
$0.26
▼ 10.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Nrc Health (NRC) Q1 2024 Earnings Call Transcript
Positive tone Sales force expansion and restructuring Generative AI and technology innovation Organizational transformation and leadership changes
Revenue
$35.31M
▼ 3.2% YoY
Diluted EPS
$0.27
▼ 3.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Nrc Health (NRC) Q4 2023 Earnings Call Transcript
Positive tone Capital returns to stockholders Core revenue and product mix Operating margin and profitability
Revenue
$38.00M*
▼ 0.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Nrc Health (NRC) Q3 2023 Earnings Call Transcript
Revenue
$37.95M
▲ 0.7% YoY
Diluted EPS
$0.32
▼ 3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Nrc Health (NRC) Q2 2023 Earnings Call Transcript
Revenue
$36.16M
▼ 3% YoY
Diluted EPS
$0.29
▼ 12.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Nrc Health (NRC) Q1 2023 Earnings Call Transcript
Revenue
$36.47M
▼ 5.1% YoY
Diluted EPS
$0.28
▼ 17.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
Nrc Health (NRC) Q4 2022 Earnings Call Transcript
Revenue
$38.14M*
▼ 0.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Nrc Health (NRC) Q3 2022 Earnings Call Transcript
Revenue
$37.69M
▼ 0.2% YoY
Diluted EPS
$0.33
▼ 13.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Nrc Health (NRC) Q2 2022 Earnings Call Transcript
Revenue
$37.29M
▲ 2.4% YoY
Diluted EPS
$0.33
▼ 5.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Nrc Health (NRC) Q1 2022 Earnings Call Transcript
Revenue
$38.44M
▲ 8.4% YoY
Diluted EPS
$0.34
▼ 5.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Nrc Health (NRC) Q4 2021 Earnings Call Transcript
Revenue
$38.30M*
▲ 10.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-08-06
Nrc Health (NRC) Q2 2020 Earnings Call Transcript
Revenue
$31.17M
▼ 0.8% YoY
Diluted EPS
$0.30
▲ 3.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Nrc Health (NRC) Q1 2020 Earnings Call Transcript
Revenue
$33.86M
▲ 7.6% YoY
Diluted EPS
$0.46
▲ 43.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Nrc Health (NRC) Q4 2019 Earnings Call
Revenue
$32.62M*
▲ 6.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–21 of 21 earnings calls
Key facts CIK 70487 CUSIP 637372202 13F (30d) 76 filings 76 filers Visit website